Overall NTHI gets a fundamental rating of 1 out of 10. We evaluated NTHI against 191 industry peers in the Pharmaceuticals industry. Both the profitability and financial health of NTHI have multiple concerns. NTHI has a expensive valuation and it also scores bad on growth.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1197.07% | ||
| ROE | N/A | ||
| ROIC | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 138.33% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -68.16 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.19 | ||
| Quick Ratio | 0.19 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
ChartMill assigns a fundamental rating of 1 / 10 to NTHI.
ChartMill assigns a valuation rating of 0 / 10 to NEONC TECHNOLOGIES HOLDINGS (NTHI). This can be considered as Overvalued.
NEONC TECHNOLOGIES HOLDINGS (NTHI) has a profitability rating of 1 / 10.